RADX
3:45 PM
Radiopharm Theranostics Achieves Confirmed Durable PartialResponse in Ongoing Phase 1 Trial of RAD204 in Patients withAdvanced Solid Tumors Post-Immunotherapy
Loading Viewer…
Trial Results • Phase 1radiopharmtheranostics.com
Loading Viewer…
Loading Viewer…